On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies into the novel coronavirus have been funded by the UK Research and Innovation government, including the first clinical drug trial in primary care, vaccine and therapy development, and studying epidemiology, disease transmission, behavioral interventions and policy approaches to COVID-19.